An unknown genetic defect increases venous thrombosis risk, through interaction with protein C deficiency

Am J Hum Genet. 1998 Aug;63(2):569-76. doi: 10.1086/301947.

Abstract

We used two-locus segregation analysis to test whether an unknown genetic defect interacts with protein C deficiency to increase susceptibility to venous thromboembolic disease in a single large pedigree. Sixty-seven pedigree members carry a His107Pro mutation in the protein C gene, which reduces protein C levels to a mean of 46% of normal. Twenty-one carriers of the mutation and five other pedigree members had verified thromboembolic disease. We inferred the presence in this pedigree of a thrombosis-susceptibility gene interacting with protein C deficiency, by rejecting the hypothesis that the cases of thromboembolic disease resulted from protein C deficiency alone and by not rejecting Mendelian transmission of the interacting gene. When coinherited with protein C deficiency, the interacting gene conferred a probability of a thrombotic episode of approximately 79% for men and approximately 99% for women, before age 60 years.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Amino Acid Substitution
  • Child
  • Female
  • Genetic Carrier Screening
  • Genetic Predisposition to Disease
  • Humans
  • Male
  • Middle Aged
  • Pedigree
  • Point Mutation*
  • Protein C / genetics*
  • Protein C Deficiency / epidemiology
  • Protein C Deficiency / genetics*
  • Risk Factors
  • Sex Characteristics
  • Venous Thrombosis / epidemiology
  • Venous Thrombosis / genetics*
  • Vermont / epidemiology

Substances

  • Protein C